Literature DB >> 12628076

Treatment of Variceal Bleeding.

Joseph J. Y. Sung1.   

Abstract

Mortality due to variceal bleeding secondary to portal hypertension has decreased significantly in the past 2 decades. Endoscopic therapy has been the mainstay of treatment for acute variceal bleeding. Variceal banding ligation has superceded injection sclerotherapy as the most popular treatment modality for acute bleeding. Multiple banding ligators are widely used with high success in restoring hemostasis. The combination of banding and sclerotherapy may be useful in preventing the early recurrence of varices and rebleeding after initial obliteration of varices. Selective vasoactive agents such as somatostatin analogs also improve the outcome of patients. Radiologic shunting has proven to be an effective salvage procedure when endoscopic treatments fail and may be a good intermediate-stage therapy while the patient is waiting for liver transplantation.

Entities:  

Year:  2003        PMID: 12628076     DOI: 10.1007/s11938-003-0018-5

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  53 in total

1.  Embolic and septic complications after sclerotherapy of fundic varices with cyanoacrylate.

Authors:  A Türler; M Wolff; D Dorlars; A Hirner
Journal:  Gastrointest Endosc       Date:  2001-02       Impact factor: 9.427

2.  Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.

Authors:  M Rössle; P Deibert; K Haag; A Ochs; M Olschewski; V Siegerstetter; K H Hauenstein; R Geiger; C Stiepak; W Keller; H E Blum
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

Review 3.  Portal hypertensive hemorrhage: pathogenesis and risk factors.

Authors:  T D Boyer
Journal:  Semin Gastrointest Dis       Date:  1995-07

4.  Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial.

Authors:  A J Sanyal; A M Freedman; V A Luketic; P P Purdum; M L Shiffman; P E Cole; J Tisnado; S Simmons
Journal:  Ann Intern Med       Date:  1997-06-01       Impact factor: 25.391

5.  Injection sclerotherapy for variceal bleeding in patients with hepatocellular carcinoma: cyanoacrylate versus sodium tetradecyl sulphate.

Authors:  J J Sung; W Yeo; R Suen; Y T Lee; S C Chung; F K Chan; P J Johnson
Journal:  Gastrointest Endosc       Date:  1998-03       Impact factor: 9.427

6.  Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial.

Authors:  G D'Amico; F Politi; A Morabito; A D'Antoni; D Guerrera; G Giannuoli; M Traina; G Vizzini; L Pasta; L Pagliaro
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

7.  Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis. Variceal Bleeding Study Group.

Authors:  A Escorsell; J M Bordas; L R del Arbol; J L Jaramillo; R Planas; R Bañares; A Albillos; J Bosch
Journal:  J Hepatol       Date:  1998-11       Impact factor: 25.083

8.  A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding.

Authors:  R Planas; J C Quer; J Boix; J Canet; M Armengol; E Cabre; T Pintanel; P Humbert; B Oller; M A Broggi
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

9.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.

Authors:  J Cabrera; M Maynar; R Granados; E Gorriz; R Reyes; J M Pulido-Duque; J L Rodriguez SanRoman; C Guerra; D Kravetz
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

10.  A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices.

Authors:  R Shields; S A Jenkins; J N Baxter; A N Kingsnorth; S Ellenbogen; C A Makin; I Gilmore; A I Morris; D Ashby; C R West
Journal:  J Hepatol       Date:  1992-09       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.